Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Mirati Therapeutics, Inc. MRTX

Set alert

Price alert · MRTX

All alert types
58.70 0.00 0.00%

At close · Jan 22

58.54 Day range 58.99

52-week range unavailable

Open
58.86
Prev close
58.70
Mkt cap
4.12B
Vol
20.96M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
58.54
High
58.99
Forward P/E
-7.01
Beta
0.77
Short ratio
2.88
Inst. own
117.76%
Dividend
0.00
Ex-div date
Earnings
Feb 27, 2024
50-d avg
57.93
200-d avg
45.92
1y target
64.50

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 6, 2023Earnings: —; estimate -2.92; surprise —%
Signals (7)
NameDateAgo
RSI: OverboughtJan 12, 20242 years ago
RSI: OverboughtJan 5, 20242 years ago
MACD: Sell SignalJan 3, 20242 years ago
MACD: Buy SignalDec 19, 20232 years ago
RSI: OverboughtDec 19, 20232 years ago
SMA: BullishNov 16, 20232 years ago
SMA: BearishNov 15, 20232 years ago

Financial health

Altman Z-Score

8.58 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.4×
FY 2013: -3.5×FY 2014: -5.7×FY 2015: -8.3×FY 2016: -1.1×FY 2017: -6.5×FY 2018: -13.3×FY 2019: -22.6×FY 2020: -27.6×FY 2021: -13.1×FY 2022: -3.4×
FY 2013 5y median -13.3× FY 2022
P/S 205×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 101×FY 2019: 1448×FY 2020: 738×FY 2021: 106×FY 2022: 205×
FY 2013 5y median 205× FY 2022
P/B 2.6×
FY 2013: 7.1×FY 2014: 8.9×FY 2015: 4.5×FY 2016: 1.9×FY 2017: 3.2×FY 2018: 6.5×FY 2019: 12.6×FY 2020: 7.3×FY 2021: 5.4×FY 2022: 2.6×
FY 2013 5y median 6.5× FY 2022
P/FCF -4.4×
FY 2013: -6.2×FY 2014: -7.5×FY 2015: -10.5×FY 2016: -1.4×FY 2017: -7.1×FY 2018: -18.7×FY 2019: -32.3×FY 2020: -35.8×FY 2021: -19.1×FY 2022: -4.4×
FY 2013 5y median -19.1× FY 2022
EV/EBITDA -3.1×
FY 2013: -5.3×FY 2014: 109×FY 2015: -6.4×FY 2016: -0.4×FY 2017: -4.3×FY 2018: -10.6×FY 2019: -19.9×FY 2020: -23.1×FY 2021: -12.7×FY 2022: -3.1×
FY 2013 5y median -12.7× FY 2022
EV/Sales 190×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 84.2×FY 2019: 1323×FY 2020: 637×FY 2021: 100×FY 2022: 190×
FY 2013 5y median 190× FY 2022
FCF Yield -22.6%
FY 2013: -16.1%FY 2014: -13.3%FY 2015: -9.6%FY 2016: -72.6%FY 2017: -14.0%FY 2018: -5.4%FY 2019: -3.1%FY 2020: -2.8%FY 2021: -5.2%FY 2022: -22.6%
FY 2013 5y median -5.2% FY 2022

Profitability

Gross Margin 95.2%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -626.2%FY 2019: -5383.2%FY 2020: -2134.3%FY 2021: -605.5%FY 2022: 95.2%
FY 2013 5y median -626.2% FY 2022
Operating Margin -6108.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -794.0%FY 2019: -6659.8%FY 2020: -2756.9%FY 2021: -795.1%FY 2022: -6108.0%
FY 2013 5y median -2756.9% FY 2022
Net Margin -5957.4%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -761.4%FY 2019: -6394.5%FY 2020: -2671.6%FY 2021: -807.0%FY 2022: -5957.4%
FY 2013 5y median -2671.6% FY 2022
ROE -74.3%
FY 2013: -204.3%FY 2014: -155.7%FY 2015: -54.6%FY 2016: -172.1%FY 2017: -49.2%FY 2018: -48.8%FY 2019: -55.8%FY 2020: -26.3%FY 2021: -41.6%FY 2022: -74.3%
FY 2013 5y median -48.8% FY 2022
ROIC -72.3%
FY 2013: -119.6%FY 2014: -138.1%FY 2015: -54.5%FY 2016: -172.6%FY 2017: -49.7%FY 2018: -50.7%FY 2019: -57.8%FY 2020: -26.3%FY 2021: -39.7%FY 2022: -72.3%
FY 2013 5y median -50.7% FY 2022
ROA -61.6%
FY 2013: -81.9%FY 2014: -130.5%FY 2015: -50.4%FY 2016: -131.0%FY 2017: -44.8%FY 2018: -43.1%FY 2019: -49.3%FY 2020: -24.2%FY 2021: -36.6%FY 2022: -61.6%
FY 2013 5y median -43.1% FY 2022

Growth (YoY)

Revenue -82.7%
FY 2013: -100.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -74.2%FY 2020: 301.7%FY 2021: 438.1%FY 2022: -82.7%
FY 2013 FY 2022
Operating Income -32.5%
FY 2013: -51.1%FY 2014: -25.2%FY 2015: -66.9%FY 2016: -29.5%FY 2017: 14.6%FY 2018: -43.5%FY 2019: -116.4%FY 2020: -66.3%FY 2021: -55.2%FY 2022: -32.5%
FY 2013 FY 2022
EPS (diluted) -17.6%
FY 2013: -134.3%FY 2014: 32.2%FY 2015: -17.9%FY 2016: -9.9%FY 2017: 33.6%FY 2018: -14.3%FY 2019: -78.4%FY 2020: -39.9%FY 2021: -40.8%FY 2022: -17.6%
FY 2013 FY 2022
Free Cash Flow -44.4%
FY 2013: -72.3%FY 2014: -11.7%FY 2015: -54.1%FY 2016: -33.6%FY 2017: 5.0%FY 2018: -8.4%FY 2019: -112.6%FY 2020: -84.8%FY 2021: -44.5%FY 2022: -44.4%
FY 2013 FY 2022

Financial Health

Current Ratio 7.0×
FY 2013: 1.7×FY 2014: 6.1×FY 2015: 12.8×FY 2016: 4.0×FY 2017: 11.4×FY 2018: 8.7×FY 2019: 8.7×FY 2020: 19.6×FY 2021: 10.5×FY 2022: 7.0×
FY 2013 5y median 8.7× FY 2022
Quick Ratio 6.9×
FY 2013: 1.7×FY 2014: 6.2×FY 2015: 12.8×FY 2016: 4.0×FY 2017: 11.4×FY 2018: 8.7×FY 2019: 8.7×FY 2020: 19.7×FY 2021: 10.5×FY 2022: 6.9×
FY 2013 5y median 8.7× FY 2022
Debt / Equity 0.1×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA 0.2×
FY 2013: 0.4×FY 2014: -14.5×FY 2015: 1.9×FY 2016: 0.7×FY 2017: 2.1×FY 2018: 2.2×FY 2019: 1.9×FY 2020: 3.7×FY 2021: 0.6×FY 2022: 0.2×
FY 2013 5y median 1.9× FY 2022
Interest Coverage 0.0×
FY 2013: -153×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31